AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis
Indian Journal of Medical Research · 2024
DOI: 10.25259/ijmr_520_23 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Indian Journal of Medical Research, 2024. Verfasst von Nur Hasnah Maamor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine & Health Sciences, UCSI University, UCSI Hospital, Negeri Sembilan, Malaysia. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, Essential Hypertension, Polymorphism, Single Nucleotide, Cytochrome P-450 CYP11B2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background & objectives The results of the genetic association studies between the selected candidate genes and hypertension (HT) contradicted across different populations. Majority of the meta-analyses carried out did not consider population genetic ancestry as a confounding factor. Therefore, this meta-analysis attempted to consolidate and re-evaluate the findings of the association between the selected candidate variants ( AGT -rs699, CYP11B2 -rs1799998, ADRB2 -rs1042713 and rs1042714) and HT, by categorizing the genotyping data based on known genetic ancestry, and/or major geographical populations.
Methods
Publications were retrieved from PubMed, Cochrane and World of Science. The included articles were further divided into different populations based on their known genetic and/or geographical ancestry.
Results
AGT rs699-G was significantly associated with HT among Indians for (i) allele [ P= 0.03, Odds ratio (OR): 1.37, 95% Confidence Interval (CI): 1.03–1.82], and (ii) dominant mode of inheritance ( P= 0.009, OR:1.45, 95% CI: 1.09–1.91). CYP11B2 rs1799998-G was significantly associated with HT in Europeans for (i) allele ( P= 6.9 × 10 –5 , OR: 0.82, 95% CI: 0.74–0.9), (ii) recessive ( P= 6.38 × 10 -5 , OR: 0.7, 95% CI: 0.59–0.83) and (iii) dominant mode of inheritance ( P= 0.008, OR: 0.81, 95% CI: 0.7–0.94). ADRB2 -rs1042713-G was significantly associated with HT in east Asians for (i) allele ( P= 0.01, OR: 1.26, 95% CI: 1.05–1.51), and (ii) recessive mode of inheritance ( P= 0.04, OR: 1.36, 95% CI: 1.01–1.83). Interpretation & conclusions Different genotype and allele frequencies in diverse populations result in different genetic associations with HT across populations. This meta-analysis finding provides an update and summary of the genetic association between the selected simple nucleotide polymorphism (SNPs) and HT across different populations and essential insights into selecting appropriate pharmacogenetic marker(s) for effective HT management in populations of different ancestries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine & Health Sciences, UCSI University, UCSI Hospital, Negeri Sembilan, Malaysia.
- Sector for Evidence-Based Healthcare, National Institute of Health, Ministry of Health Setia Alam, Malaysia.
- UiTM Private Specialist Centre, Jalan Hospital, Selangor, Malaysia.
- Cardiology Unit, Prince Court Medical Centre, Kuala Lumpur, Malaysia.
- MAA Medicare Cardiac Diagnostic Centre, Kuala Lumpur, Malaysia.
- Faculty of Medicine, Universiti Teknologi MARA, Jalan Hospital, Selangor, Malaysia.
Zitieren
APA
Maamor, N. H., Ismail, J., Malek, K. A., Yusoff, K., & Boon-Peng, H. (2024). AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis. Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_520_23
Vancouver
Maamor NH, Ismail J, Malek KA, Yusoff K, Boon-Peng H. AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis. Indian Journal of Medical Research. 2024. doi:10.25259/ijmr_520_23
BibTeX
@article{Maamor2024,
author = {Maamor, Nur Hasnah and Ismail, Johanrizwal and Malek, Khasnur Abd and Yusoff, Khalid and Boon-Peng, Hoh},
title = {AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis},
journal = {Indian Journal of Medical Research},
year = {2024},
doi = {10.25259/ijmr_520_23}
}
EUVIMED